Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

New Frontier in Regenerative Medicine: Site-Specific Gene Correction in Patient-Specific Induced Pluripotent Stem Cells

15 May 2013

Abstract excerpt

Advances in cell and gene therapy are opening up new avenues for regenerative medicine. Because of their acquired pluripotency, human induced pluripotent stem cells (hiPSCs) are a promising source of autologous cells for regenerative medicine. They show unlimited self-renewal while retaining the ability, in principle, to differentiate into any cell type of the human body. Since Yamanaka and colleagues first...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomedical Ethics and Regulation
Share to CRISPR and Genetic Engineering
Share to Pluripotent Stem Cells Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23675640
DOI: 10.1089/hum.2012.251

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

New Frontier in Regenerative Medicine: Site-Specific Gene Correction in Patient-Specific Induced Pluripotent Stem CellsPMID 23675640Read ↗

CRISPR‐Cas9‐Based Genome Editing of Human Induced Pluripotent Stem CellsSemantic proximity Read ↗

Genome Editing in Human Pluripotent Stem Cells: Approaches, Pitfalls, and Solutions.Semantic proximity Read ↗

Gene Editing of Human Hematopoietic Stem and Progenitor Cells: Promise and Potential HurdlesSemantic proximity Read ↗

Genetic Modification in Human Pluripotent Stem Cells by Homologous Recombination and CRISPR/Cas9 System.Semantic proximity Read ↗

Induced Pluripotency and Gene Editing in Disease Modelling: Perspectives and ChallengesSemantic proximity Read ↗

Homology-directed gene-editing approaches for hematopoietic stem and progenitor cell gene therapySemantic proximity Read ↗

Development of an efficient single-cell cloning and expansion strategy for genome edited induced pluripotent stem cellsSemantic proximity Read ↗

CRISPR/Cas9-Mediated Introduction of Specific Heterozygous Mutations in Human Induced Pluripotent Stem Cells.Semantic proximity Read ↗

Genome editing in induced pluripotent stem cellsSemantic proximity Read ↗

Find and replace: editing human genome in pluripotent stem cells.Semantic proximity Read ↗

TALEN-mediated generation and genetic correction of disease-specific human induced pluripotent stem cells.Semantic proximity Read ↗

Homologous Recombination in Human Embryonic Stem Cells: A Tool for Advancing Cell Therapy and Understanding and Treating Human DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.